Ptc Therapeutics Inc (PTCT)

R&D Expense Growth

-14.82%

Fiscal year · Period ending:

PTCT logo

PTCT R&D Expense Growth

Latest reported-14.82%
PTCT FY R&D Growth (YoY) (0.00% → -14.82%)
High-resolution chart · PNG

PTCT r&d expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Ptc Therapeutics Inc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
-14.8239%
-19.8155%
2.3127%
20.4948%
13.1984%
85.527%
49.6953%
46.4242%
-0.1505%
-3.4339%
52.579%
45.4903%
18.9347%
-21.3682%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.